1-5 of 5
clofazimine
Close
Sort by
Journal Articles

Repurposing Clofazimine As a Novel Drug for the Treatment of PI-Resistant Stem Cell-like Subclones in Myeloma

Harish Kumar, PhD, Ujjal Kumar Mukherjee, PhD, Suman Mazumder, PhD, Sabyasachi Sanyal, PhD, Brian G. Van Ness, PhD, Amit Kumar Mitra, PhD MSc, BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 4418.
https://doi.org/10.1182/blood-2019-131596
Published: 2019
Journal Articles

Synergistic Effect of Carfilzomib and Metformin in Vascular Plasticity; The Emerging Role of Autophagy

Panagiotis Efentakis, PhD, Ioanna Andreadou, PhD, Panagiota-Efstathia Nikolaou, PhD, Claudius Witzler, Svenja Siemer, Eftathios Kastritis, Philip Wenzel, MD PhD, Meletios A. Dimopoulos, MD, Evangelos Terpos, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3797.
https://doi.org/10.1182/blood-2019-123522
Published: 2019
Journal Articles

Anti-Cancer Effects of Clofazimine As a Single Agent and in Combination with Cisplatin in Multiple Myeloma

Ipek Durusu, PhD, Hazal Hepsen Husnugil, Heval Atas, Aysenur Biber, Selin Gerekci, Aliye Ezgi Gulec, Can Ozen, Assoc. Prof.
Journal: Blood
Blood (2016) 128 (22): 5897.
https://doi.org/10.1182/blood.V128.22.5897.5897
Published: 2016
Journal Articles

Methemoglobinemia Secondary to Clofazimine Treatment for Chronic Graft-Versus-Host Disease

Vaneuza de A. Moreira, Bruno C. De Medeiros, Carmen M.S. Bonfim, Ricardo Pasquini, Carlos R. De Medeiros
Journal: Blood
Blood (1998) 92 (12): 4872–4873.
https://doi.org/10.1182/blood.V92.12.4872
Published: 1998
Journal Articles

Treatment of Chronic Graft-Versus-Host Disease With Clofazimine

Stephanie J. Lee, Scott A. Wegner, Carol J. McGarigle, Barbara E. Bierer, Joseph H. Antin
Journal: Blood
Blood (1997) 89 (7): 2298–2302.
https://doi.org/10.1182/blood.V89.7.2298
Published: 1997